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Olfactory Dysfunction Predicts 5-Year Mortality in Older
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Abstract
Prediction of mortality has focused on disease and frailty, although antecedent biomarkers may herald broad physiological
decline. Olfaction, an ancestral chemical system, is a strong candidate biomarker because it is linked to diverse physiological
processes. We sought to determine if olfactory dysfunction is a harbinger of 5-year mortality in the National Social Life,
Health and Aging Project [NSHAP], a nationally representative sample of older U.S. adults. 3,005 community-dwelling adults
aged 57–85 were studied in 2005–6 (Wave 1) and their mortality determined in 2010–11 (Wave 2). Olfactory dysfunction,
determined objectively at Wave 1, was used to estimate the odds of 5-year, all cause mortality via logistic regression,
controlling for demographics and health factors. Mortality for anosmic older adults was four times that of normosmic
individuals while hyposmic individuals had intermediate mortality (p,0.001), a ‘‘dose-dependent’’ effect present across the
age range. In a comprehensive model that included potential confounding factors, anosmic older adults had over three
times the odds of death compared to normosmic individuals (OR, 3.37 [95%CI 2.04, 5.57]), higher than and independent of
known leading causes of death, and did not result from the following mechanisms: nutrition, cognitive function, mental
health, smoking and alcohol abuse or frailty. Olfactory function is thus one of the strongest predictors of 5-year mortality
and may serve as a bellwether for slowed cellular regeneration or as a marker of cumulative toxic environmental exposures.
This finding provides clues for pinpointing an underlying mechanism related to a fundamental component of the aging
process.
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Indeed, olfactory dysfunction presages major neurodegenerative
diseases including Alzheimer’s disease and Parkinson’s disease,
assessed both clinically and post-mortem, and even mild cognitive
impairment [17–19]. Given that olfaction has multiple roles and
relies on peripheral and central cell regeneration, we hypothesized
that olfactory dysfunction could be an early integrative indicator of
impending death.
To answer this question, we included olfactory function in the
National Social Life, Health, and Aging Project (NSHAP), a
nationally representative study of community-dwelling older adults
[20–25]. NSHAP is the first population-based survey to objectively
measure olfaction and generated a rich array of health and social
information as well as a five year follow-up that determined
mortality [26]. We examined whether olfactory dysfunction
predicted mortality after 5 years, utilizing the available health
and social information to evaluate potential confounders and test
putative mechanisms.

Introduction
Olfaction is a critical, if underappreciated, component of
human physiology. Although potentially less dependent on
olfaction than many other mammals [1], humans still rely on this
ancestral system which plays an essential role in health and
behavior. For example, the olfactory system maintains adequate
nutrition through appetite and food preferences [2,3], enables
detection of environmental hazards and pathogens, is associated
with memory, emotions and intimate social relationships [4,5] [6]
and is linked neuroanatomically with key parts of the central
nervous system [7–9]. Finally, normal olfactory function depends
on cellular regeneration of the olfactory neuroepithelium, bulb
and hippocampus [10–12], a capacity impaired by telomere
shortening which is a hallmark of aging in many systems [13].
Mortality prediction has typically focused on proximate causes
of death such as disease [14] and life-limiting conditions such as
frailty [15,16] and dementia, along with associated biomarkers.
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(excellent to poor), poor appetite based on ‘‘During the last
week…I did not feel like eating; my appetite was poor’’ (‘‘rarely/
none of the time’’ to ‘‘most of the time’’), and body-mass index
(BMI). Inability to perform one or more of seven activities of daily
living (ADL) quantified frailty (a biologic syndrome defined by
weakness, unintentional weight loss, exhaustion, and lower
physical activity, resulting from cumulative declines across
multiple physiologic systems, and causing higher morbidity and
mortality [15]) [33].
Cognitive function (specifically memory and mental arithmetic)
was measured with a modified version of the Short Portable
Mental Status Questionnaire (SPMSQ) [34]. Self-rated mental
health was measured by a standard 5-point scale (excellent, very
good, good, fair, or poor). Health behaviors affecting olfaction
were current smoking, based on either salivary cotinine level or
self-report, and problem drinking [22,35].

Methods
Subjects
NSHAP is the first study of social relationships and health of
older adults in a probability sample representative of the United
States. In 2005–6 (Wave 1) professional interviewers (National
Opinion Research Center [NORC]) conducted in-home interviews with 3,005 community-dwelling older adults (1,454 men and
1,551 women) 57–85 years of age living throughout the US
[20,21]. Five years later, data were collected again (2010–11,
Wave 2). To investigate health disparities, race was self-identified
using standard NIH classifications. American Indian, Asian, or
others formed a single category (‘‘Other’’). Further details
regarding design, data collection, and baseline characteristics of
NSHAP respondents are provided elsewhere [20,21,27]. The
study was approved by the Institutional Review Boards of The
University of Chicago and NORC; all respondents provided
written, informed consent.

Statistical Analysis
NSHAP had a 75.5% survey response rate in Wave 1, excellent
for a targeted probability sample, and the non-responders were
similar demographically to the responders [31]. Estimates of the
prevalence and mean values in the US population were based on
weights accounting for differential probabilities of non-response
and selection. Design-based standard errors were calculated using
the linearization method [36] together with the strata and Primary
Sampling Unit indicators provided with the dataset. In Wave 2,
NSHAP had a 99.7% determination of mortality. Statistical
analyses were conducted with Stata Version 13.0 (Stata Corp LP,
College Station, Texas, USA).
We treated the degree of olfactory dysfunction (anosmia,
hyposmia, or normosmia) or the number of odors incorrectly
identified (0–5) as the independent variable and death as the
dependent variable in separate analyses. Multivariate logistic
regression was used to model the relationship between olfactory
dysfunction and covariates of interest at Wave 1 and death at
Wave 2. P-values (all two-sided) and 95% confidence intervals
were based on the corresponding Wald statistic. The marginal
effects of hyposmia and anosmia on the probability of 5-year
mortality were plotted, versus both age alone and the percentiles of
a composite risk score computed as a linear combination of several
factors affecting the likelihood of death (with coefficients estimated
from the logistic model). Sensitivity analyses included: (1) refitting
the regression models excluding one identification item at a time
(to ensure that a single odor was not unduly affecting the results),
(2) an analysis of morbidity and mortality, combining those
subjects who were too sick to interview in Wave 2 with those who
had died, and (3) an analysis that excluded those reporting a
history of head trauma or nasal surgery.
To investigate possible non-linear effects of age, we constructed
models which included age2. This quadratic term was not
statistically significant (data not shown) and did not change the
estimate of the olfaction effect on mortality. For parsimony, this
term was not included in the models presented here. We also
determined whether there were gender differences in associations
between olfaction and mortality by: (1) fitting separate models for
each gender, and (2) including all gender interaction terms in a
gender-pooled model. In neither analysis did the magnitude of the
olfaction effect change, nor was there evidence for gender
differences. Again, models without the interaction terms are
presented here for parsimony.

Assessment of Olfactory Function in Wave 1
Olfactory function was assessed using a validated odor
identification test presented using felt-tipped pens [28] (Burghart
Messtechnik, Wedel, Germany). To accommodate the survey’s
logistical and time constraints, five odorants were selected and
presented one at a time. Respondents were asked to identify each
by choosing from a set of four picture/word prompts in a forced
choice protocol [26]; refusals were coded as incorrect (for test
details, see [22,29]). The target odors were rose, leather, orange,
fish, and peppermint. The number of incorrectly identified odors
yielded an empiric score (normosmia cutoff based on [30]), which
was used to categorize severity of olfactory dysfunction: anosmic
= 4–5 errors, hyposmic = 2–3 errors, and normosmic = 0–1 error.

Determination of Mortality at Wave 2
Mortality status at Wave 2 was confirmed either by speaking
with the respondent (alive) or by conducting a proxy interview
with a family member or neighbor or examining public records or
news sources. Cases were pursued to determine whether respondents were likely alive but not accessible for re-interview. Of the
3,005 Wave 1 respondents, 430 were deceased 5 years later and
2,565 were alive (2,261 reinterviewed, 143 too sick to interview,
and 161 determined to be alive but unavailable for interview).
There were only 10 cases in which it was unknown whether the
respondent was living or not; these were excluded from these
analyses. An additional 77 respondents were excluded from the
analyses because they had missing data in one of the primary
independent variables (odor identification, demographics, and
comorbidity index), leaving N = 2,918 for analyses.

Common Mortality Risk Factors
To adjust for factors known to be associated with mortality, we
included a number of covariates in our analyses, many of which
have also been found to be associated with olfaction. Age was
categorized into groups (57–64 years, 65–74 years, 75–85 years)
according to the sampling strategy of the overall study [31].
Socioeconomic status was measured by education (highest degree
or certification earned) and net household assets (house, cars, or
rental properties/businesses owned; financial assets including
savings accounts, stocks, and pensions minus outstanding debt).
We present models using only education because both measures
yielded similar results. Comorbid diseases were assessed with the
Charlson Index modified for NSHAP [32]. In addition, respondents reported whether a doctor had ever told them they had a
particular disease. Nutrition measures included self-reported taste
PLOS ONE | www.plosone.org

2

October 2014 | Volume 9 | Issue 10 | e107541

Olfaction and Mortality in Older Adults

Despite the possibility that medical conditions might account for
these findings [22], the addition of a comorbidity index, a
validated summary measure, did not reduce the magnitude of the
effect (Model C, Table 2). Including specific diseases that are
major risk factors for death in older adults (cardiovascular diseases,
cancer, lung disease, stroke, diabetes and liver damage) (Model D,
Table 2) did not attenuate the effect of olfactory function on
mortality, confirming that our results were not an artifact of using
a summary measure of comorbidity. Anosmia was a markedly
stronger risk factor than most chronic diseases (See Figure 2).
The effect was strikingly robust, with anosmic adults retaining a
high likelihood of dying in 5 years that was essentially unchanged
(Model D: OR, 3.37 [95%CI 2.04, 5.57]). Increased comorbidity
was associated with death (OR, 1.36 [95%CI 1.28, 1.45]) and
individual conditions associated with death included heart failure
(OR, 2.16 [95%CI 1.29, 3.62]), stroke (OR, 2.04 [95%CI 1.51,
2.76]), diabetes (OR, 2.07 [95%CI 1.52, 2.82]), and liver damage
(OR, 5.15 [95%CI 1.75, 15.12]). Only severe liver damage was a
stronger predictor of death than anosmia.
This effect was substantial enough to identify those at higher risk
of mortality above and beyond other causes of death. Figure 3
shows the effect of anosmia beyond the effects of age alone (A) and
age together with the other variables in Model C (B) on the
probability of 5-year mortality, averaged across the entire
population. For example, among those already at an elevated risk
of death (at the 75th percentile of composite risk score), anosmia
increased the average probability of death to 0.39 from 0.16 for
normal smellers.
To determine if the effect on mortality was being driven only by
those with severe olfactory loss, we refit Model C using the number
of olfactory errors to determine whether each additional error
increased mortality risk (p,0.001 trend test, Figure 1B). Even
when anosmics were excluded from the analysis, the number of

Results
Olfactory Dysfunction, Mortality and Diseases
Demographic, olfactory and health characteristics of the US
population 57–85 years of age are presented in Table 1. The
weighted 5-year mortality rate among the analytic sample was
12.5%, consistent with what would be expected based on the
Social Security Administration (SSA) life tables[37]. Fully 39% of
older adults with anosmia were dead at Wave 2, 19% of those with
hyposmia and only 10% of those with normal olfaction (p,0.001),
a dose-dependent pattern seen in all age groups (Figure 1A). This
translated into a strikingly increased odds of death for anosmic
(OR, 5.85 [95%CI 3.76, 9.10]) and hyposmic older adults (OR,
2.20 [95%CI 1.61, 3.02]) compared to those with normal olfactory
function (Model A, Table 2).
Because these effects may simply reflect an association between
olfaction and other factors increasing mortality, we then controlled
for age (older people face higher odds of death), gender (men are
more likely to die than women), socioeconomic status as measured
by education level or assets (more educated or wealthier people are
less likely to die), and race (racial health disparities may affect odds
of death) (Model B, Table 2).
Older age increased the likelihood of death (OR, 1.07 [95%CI
1.05, 1.09]), whereas women had a lower likelihood of death (OR,
0.70 [95%CI 0.53, 0.93]) as did those with higher education (OR,
0.72 [95%CI 0.63, 0.82]); using assets yielded similar results.
Despite adjusting for these demographic variables, those with
anosmia still showed a substantially increased odds of death
compared to those with normal olfactory function (OR, 3.24
[95%CI 1.99, 5.28]), and a smaller though statistically significant
difference was also observed among hyposmic adults (OR, 1.54
[95%CI 1.10, 2.16]).

Figure 1. A. Olfactory dysfunction and 5-year mortality in three age groups (ages 57–64, 65–74, and 75–85 years). B. Progressive increase in 5-year
mortality with each additional error in odor identification (p,0.001 from one degree of freedom test for trend); from logistic regression as in Model C
Table 2, with number of odor identification errors.
doi:10.1371/journal.pone.0107541.g001
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Table 1. Demographic, olfactory and health characteristics of the population (N = 2,918).

N

Estimated% of US Population

417

12.5

0

1,281

48.5

1

863

29.2

2

475

13.9

3

178

4.9

4

85

2.4

5

36

1.1

Sex (% men)

1,423

48.9

Mortality status at Wave 2 (% dead)
Odor identification (# of errors)

a

Race/ethnicity
White

2,072

80.9

African American (AA)

487

9.8

Hispanic (non-AA)

291

6.8

Other

68

2.5

Education
,High school (HS)

674

18.3

HS graduate or equiv.

765

26.8

Some college

832

30.1

Bachelors or higher

647

24.8

Disease Conditions
Hypertension

1,676

54.0

Diabetes

630

19.9

Cancerb

365

12.6

Heart attack

349

11.6

Emphysema or COPDc

311

11.1

Heart failure

276

8.2

Stroke

261

8.1

Liver damage

33

1.1

Age (mean6SDd, range)

68.067.7, 57–85

Comorbidity Index (mean6SDd, range)

1.861.7, 0–10.5

a

0–1 error = Normosmic, 2–3 errors = Hyposmic, 4–5 errors = Anosmic.
Excluding skin cancer.
c
COPD = Chronic obstructive pulmonary disease.
d
SD = standard deviation.
doi:10.1371/journal.pone.0107541.t001
b

errors was still associated with 5-year mortality (p = 0.041 trend
test). Thus, even mild olfactory dysfunction was associated with
increased odds of death. We also verified that mortality risk was
not being driven by failure to detect one particular odor (Table S1
in File S1). Thus, lack of familiarity or culture bias did not explain
our results.

work [38–40], Nonetheless, including these variables in the model
did not change the magnitude of the association between anosmia
and mortality, which remained highly significant (OR, 3.29
[95%CI 1.78, 6.07]).
Olfaction and neurodegenerative diseases are linked clinically
and pathologically, so we next determined whether cognitive
function mediated the observed effect of an inability to identify
odors on mortality. Those with impaired cognition were more
likely to die (OR, 1.30 [95%CI 1.17, 1.44] per additional error on
the SPMSQ). Controlling for cognitive function resulted in a small
but significant diminution of the effect of anosmia on mortality
(OR, 2.80 [95%CI 1.61, 4.86]) (Table S2 in File S1). This
indicates cognitive deficits may be one small component explaining the effect of odor identification on mortality, but does not
account for the majority of the role olfaction plays on this
outcome.
Because mental health, and health behaviors, such as smoking
and alcohol use, could also affect both olfaction and mortality, we

Potential Mechanisms
To test possible mechanisms, we added the corresponding
variables to Model C to see if they accounted for the effects of
olfactory dysfunction on mortality. First, we tested reduced
nutrition by including self-reported taste function (recall that
flavor perception is actually due to olfactory function), whether the
respondent enjoyed eating, and BMI (Table S2 in File S1). Those
who did not enjoy eating (OR, 1.22 [95%CI 1.01, 1.47]) or were
underweight (OR, 3.88 [95%CI 1.29, 11.69]) were more likely to
die after 5 years. However, those who were overweight had lower
mortality (OR, 0.59 [95%CI 0.38, 0.92]), consistent with prior
PLOS ONE | www.plosone.org
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Table 2. Effects of olfactory dysfunction on death (logistic regression Model A), controlling for demographic variables (Model B),
comorbidity index (Model C) and common diseases causing death (Model D) in older adults.

Odds Ratio, 95% Confidence Interval, p value
Covariates
Olfactory dysfunction (vs. Normosmic)
Anosmic

Hyposmic

Model A

Model B

Model C

Model D

5.851

3.24

3.41

3.37

(3.76,9.10)2

(1.99,5.28)

(2.06,5.64)

(2.04,5.57)

,0.0013

,0.001

,0.001

,0.001

2.20

1.54

1.48

1.47

(1.61,3.02)

(1.10,2.16)

(1.03,2.14)

(1.00,2.17)

,0.001

0.01

0.04

0.05

a

Age (per year)

Female gender

1.07

1.06

1.07

(1.05,1.09)

(1.04,1.09)

(1.05,1.09)

,0.001

,0.001

,0.001

0.70

0.74

0.83

(0.53,0.93)

(0.55,1.00)

(0.62,1.10)

0.02

0.05

0.19

Race/ethnicity (vs. White)
African American

Hispanic

Other

Educationb

Comorbidity Index

0.91

0.88

0.86

(0.65,1.27)

(0.62,1.24)

(0.60,1.23)

0.58

0.45

0.40

0.57

0.61

0.58

(0.36,0.89)

(0.36,1.02)

(0.34,0.99)

0.01

0.06

0.05

0.84

0.88

0.89

(0.39,1.81)

(0.38,2.06)

(0.37,2.15)

0.65

0.77

0.80

0.72

0.76

0.77

(0.63,0.82)

(0.66,0.87)

(0.67,0.88)

,0.001

,0.001

,0.001

1.36
(1.28,1.45)
,0.001

Heart attack

1.51
(0.97,2.33)
0.06
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Table 2. Cont.

Odds Ratio, 95% Confidence Interval, p value
Covariates

Model A

Model B

Model C

Heart failure

Model D
2.16
(1.29,3.62)
0.004

Stroke

2.04
(1.51,2.76)
,0.001

Diabetes

2.07
(1.52,2.82)
,0.001

Hypertension

0.84
(0.64,1.10)
0.20

Emphysema/COPDc

1.32
(0.94,1.86)
0.11

Liver damage

5.15
(1.75,15.12)
0.004

Cancerd

1.39
(0.95,2.02)
0.09

(N = 2,918; 1Odds ratio, 295% Confidence interval, 3p value).
a
0–1 error = Normosmic, 2–3 errors = Hyposmic, 4–5 errors = Anosmic.
b
Treated as a continuous measure using integer scores for educational level (higher scores = more education.).
c
COPD = Chronic obstructive pulmonary disease.
d
Excluding skin cancer.
doi:10.1371/journal.pone.0107541.t002

factor for death, stronger than several common causes of death,
such as heart failure, lung disease and cancer, indicating that this
evolutionarily ancient special sense may signal a key mechanism
that affects human longevity. This effect is large enough to identify
those at a higher risk of death even after taking account of other
factors, yielding a 2.4 fold increase in the average probability of
death among those already at high risk (Figure 3B). Even among
those near the median risk, anosmia increases the average
probability of death from 0.09 (for normal smellers) to 0.25.
Thus, from a clinical point of view, assessment of olfactory
function would enhance existing tools and strategies to identify
those patients at high risk of mortality.
We excluded several possibilities that might have explained
these striking results. Adjusting for nutrition had little impact on
the relationship between olfactory dysfunction and death. Similarly, accounting for cognition and neurodegenerative disease and
frailty also failed to mediate the observed effects. Mental health,
smoking, and alcohol abuse also did not explain our findings. Risk
factors for olfactory loss (male gender, lower socioeconomic status,

included these in our models, with no reduction in the effect of
anosmia on mortality (including mental health: OR, 3.43 [95%CI
2.06, 5.69]; including smoking and alcohol use: OR, 3.56 [95%CI
2.10, 6.05]) (Table S2 in File S1). We note that smoking causes
increased mortality, and loss of olfactory function [42], although
studies have not always found this effect on olfaction [41].
We then examined whether frailty, a predictor of mortality,
mediated the relationship. Those who could not independently
perform at least one activity of daily living had a higher risk of
death compared to those without any ADL disability (OR, 2.22
[95%CI 1.63, 3.03]) (Table S2 in File S1), but controlling for ADL
disability did not reduce the main effect of anosmia on death (OR,
3.69 [95%CI 2.22, 6.13]).

Discussion
We are the first to show that olfactory dysfunction is a strong
predictor of 5-year mortality in a nationally representative sample
of older adults. Olfactory dysfunction was an independent risk

PLOS ONE | www.plosone.org
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Figure 2. Odds for 5-year mortality for olfactory dysfunction compared to most common causes of death. Odds ratios with 95%
confidence intervals are displayed in forest plot format. Confidence intervals that do not cross the vertical dashed line (odds ratio = 1) indicate
statistical significance at the 0.05 level. Heart attack refers to myocardial infarction, whereas heart failure refers to congestive heart failure.
doi:10.1371/journal.pone.0107541.g002

BMI) were included in our analyses, and though they replicated
prior work [41], did not affect our results.
Our study does have a few notable limitations. Because our 5item olfactory test is less reliable than a longer assessment, our
results likely represent an underestimate of the magnitude of the

association between olfactory dysfunction and mortality. In
addition, the home setting in which the interviews were conducted
precluded assessments of physiological and anatomical characteristics typically performed in the clinic or hospital. Finally, our

Figure 3. Effect of olfactory ability on the mean predicted probability of 5-year mortality, adjusting for age (A) and composite
mortality risk score composed of all variables in Model C except olfaction (B). At the 75th percentile of composite mortality risk, anosmia
increases the average probability of death to 0.39 from 0.16 for normal smellers.
doi:10.1371/journal.pone.0107541.g003
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dataset does not include cause of death, data that would permit
additional exploration of specific mechanisms.
We believe olfaction is the canary in the coalmine of human
health, not that its decline directly causes death. Olfactory
dysfunction is a harbinger of either fundamental mechanisms of
aging, environmental exposure, or interactions between the two.
Unique among the senses, the olfactory system depends on stem
cell turnover, and thus may serve as an indicator of deterioration
in age-related regenerative capacity more broadly or as a marker
of physiologic repair function [13].
The olfactory nerve is the only cranial nerve directly exposed to
the environment. Thus, it is possible that respiratory exposures
(pollution, toxins, pathogens) could reach the central nervous
system via the olfactory nerve and cause death due to direct
injurious effects, consistent with the olfactory vector hypothesis of
neurodegenertives diseases[43,44]. Alternatively, these exposures
could be absorbed and cause systemic effects (e.g., pulmonary,
cardiovascular systems) resulting in death as they simultaneously
injure the olfactory epithelium. Particulate matter pollution has
been shown to increase morbidity and mortality and decrease
olfaction, although the precise mechanism of these effects is
unknown [45]. Further investigation is required to distinguish
which of these etiologies may explain our results. Another open
question for future work is whether this relationship is present in
younger adults.
The test we employed here is a shortened version of a standard
olfactory test used clinically, taking only ,3 minutes to deploy and
score. Despite this, our method is able to distinguish groups with
substantial differences in mortality. Thus, this short olfactory test
may have clinical utility in identifying patients at risk and who
might benefit from additional clinical scrutiny and further followup. Our results extend the existing literature on biomarkers of
mortality including functional and physiological measures, with
the ability of olfaction to predict death as large as, if not exceeding,
other biomarkers [46–53]. To our knowledge, no previous study
has examined sensory function as a predictor of mortality in a

nationally representative population sample. Thus, our results
have broad implications for understanding mortality of older
adults in the US and worldwide.

Supporting Information
File S1 This file contains Table S1 and Table S2. Table
S1, Logistic regressions, each excluding one odor to determine if it
in particular was driving the effect (adjusting for age, gender, race/
ethnicity, education and comorbidity index; N = 2,918). Table S2,
Factors possibly mediating the effect of olfactory dysfunction on
mortality: nutrition, cognition, mental health, health behaviors,
and frailty.
(DOCX)
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